Generalized anxiety disorder reduction
A landmark Penn Medicine RCT demonstrated chamomile extract (1,500 mg/day) significantly reduced GAD symptom scores on the Hamilton Anxiety Rating Scale vs. placebo over 8 weeks — the first large, well-designed RCT establishing chamomile as a clinically meaningful natural anxiolytic. Long-term use (26 weeks) reduced relapse risk by 56% vs. placebo withdrawal.
Sleep quality and insomnia improvement
Multiple clinical studies confirm chamomile improves sleep quality, reduces time to fall asleep, and improves next-day functioning in adults with insomnia and sleep disturbances. Apigenin's GABA-A receptor binding produces sedative effects without the dependency or rebound insomnia of pharmaceutical sleep aids.
Digestive health and antispasmodic effects
Chamomile is one of the most used herbal remedies for GI complaints — functional dyspepsia, colic, gastritis, and IBS symptoms. Alpha-bisabolol reduces gastric inflammation, while the antispasmodic flavonoids relax intestinal smooth muscle to reduce cramping, bloating, and bowel irregularity.
Anti-inflammatory activity
Chamomile's chamazulene (formed during steam distillation) and alpha-bisabolol inhibit COX-2 and 5-LOX pathways, reducing prostaglandin and leukotriene production. Clinical studies confirm topical and oral chamomile reduces inflammatory markers — supporting use for mild inflammatory conditions.
Blood sugar regulation
A 8-week RCT showed chamomile tea (3 cups/day) significantly reduced fasting blood glucose, HbA1c, insulin, and HOMA-IR in type 2 diabetic patients vs. water control. Alpha-glucosidase inhibition and antioxidant protection of beta cells are proposed mechanisms.
Apigenin GABA-A receptor partial agonism
Apigenin — chamomile's primary flavonoid — binds the benzodiazepine site on GABA-A receptors as a partial agonist, enhancing inhibitory GABA neurotransmission and producing sedative-anxiolytic effects. Unlike benzodiazepines, apigenin's partial agonism produces milder effects without tolerance development or dependency risk.
Alpha-bisabolol anti-inflammatory and GI protective activity
Alpha-bisabolol inhibits NF-κB activation, reduces COX-2 expression, and protects gastric mucosa from irritant-induced damage. This anti-inflammatory and gastroprotective mechanism explains chamomile's efficacy for both systemic inflammation and GI-specific complaints.
Adenosine receptor modulation for sleep
Apigenin also binds central benzodiazepine receptors and modulates adenosine A1 receptors — contributing to sedative and sleep-promoting effects through both GABAergic and adenosinergic pathways simultaneously. This dual mechanism produces more natural sleep induction than single-pathway sleep aids.
Randomized, double-blind, placebo-controlled trial of chamomile extract (1,500 mg/day) vs. placebo in 179 adults with DSM-defined GAD for 8 weeks, with 26-week relapse prevention extension.
179 adults with GAD. 8-week treatment + 26-week relapse prevention.
Chamomile significantly reduced HAM-A scores vs. placebo. Sustained use reduced relapse rate by 56% vs. placebo withdrawal. Long-term chamomile use safe and effective for GAD maintenance. First robust RCT establishing chamomile for anxiety.
Randomized controlled trial of chamomile tea (3 cups/day) vs. water in 64 type 2 diabetic patients for 8 weeks.
64 T2DM patients. 8-week intervention.
Chamomile tea significantly reduced fasting blood glucose, HbA1c, insulin, HOMA-IR, and antioxidant markers vs. water control. Supports chamomile as a safe daily beverage adjunct for blood sugar management.